1. Design and development of novel 1,2,3-triazole chalcone derivatives as potential anti-osteosarcoma agents via inhibition of PI3K/Akt/mTOR signalling pathway
   Qing Su et al, 2022, Acta Pharmaceutica CrossRef
2. Targeted Inhibition of the PI3K/Akt/mTOR Signaling Axis: Potential for Sarcoma Therapy
   Atif Khurshid Wani et al, 2024, Mini-Reviews in Medicinal Chemistry CrossRef
3. Alantolactone induces platelet apoptosis by activating the Akt pathway
   Yueyue Sun et al, 2023, Platelets CrossRef
4. A four-lncRNA risk signature for prognostic prediction of osteosarcoma
   Huanlong Liu et al, 2023, Frontiers in Genetics CrossRef
5. Alantolactone: A Natural Plant Extract as a Potential Therapeutic Agent for Cancer
   Yuan Cai et al, 2021, Frontiers in Pharmacology CrossRef